These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 14255287

  • 21. [Effects of caffeinated ergotamine tartrate in migraine attacks (E. C. 110 or cafergon); first results].
    GIRARD M.
    Lyon Med; 1950 May 28; 183(22):345-8. PubMed ID: 15438042
    [No Abstract] [Full Text] [Related]

  • 22. [Effects of caffeinated ergotamine tartrate in migraine attacks; E. C. 110 or cafergon; first results].
    GIRARD M.
    J Med Chir Prat; 1950 Aug 28; 121(8):165-9. PubMed ID: 24538126
    [No Abstract] [Full Text] [Related]

  • 23. [ON THE POSITION OF CHANOCLAVINE IN ALKALOID METABOLISM BY CLAVICEPS PURPUREA TUL].
    VOIGT R, BORNSCHEIN M.
    Pharmazie; 1964 May 28; 19():342-4. PubMed ID: 14235097
    [No Abstract] [Full Text] [Related]

  • 24. Effects of adrenaline and ergotamine on the oxygen consumption.
    LUNDHOLM L, MOHME E.
    Acta Physiol Scand; 1949 Jan 22; 16(4):367-88. PubMed ID: 18128141
    [No Abstract] [Full Text] [Related]

  • 25. Headache as seen by the otolaryngologist with special reference to the use of cafergone-E.C. 110 ergotamine tartrate and caffeine for the relief of attacks.
    HILSINGER RL.
    Christ Hosp Med Bull; 1949 Apr 22; 2(4):85-93. PubMed ID: 18130723
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Chemical and pharmacological studies on the in-vitro cultured ergot. I.
    Ogiu K, Shimamoto K.
    Jpn J Pharmacol; 1952 Sep 22; 1(1):35-43. PubMed ID: 14945926
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Some recent developments on the pharmacology of ergot of rye].
    ROTHLIN E, FANCHAMPS A.
    Rev Pathol Gen Physiol Clin; 1955 Dec 22; 55(673):1427-43. PubMed ID: 13298391
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of ergotamine tartrate on potassium changes in histamine shock.
    TUM SUDEN C.
    Proc Soc Exp Biol Med; 1947 Apr 22; 64(4):464. PubMed ID: 20239459
    [No Abstract] [Full Text] [Related]

  • 36. Clinical observations on the mechanism of hypertensive headache and the results of its treatment with dihydro-ergotamine tartrate.
    BIRCHALL R, TAYLOR RD, PAGE IH.
    Cleve Clin Q; 1946 Oct 22; 13(4):227-31. PubMed ID: 20274028
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The pharmacognosy of smooth brome ergot.
    JONES DD, TYLER VE.
    J Am Pharm Assoc Am Pharm Assoc; 1955 Aug 22; 44(8):480-3. PubMed ID: 13242443
    [No Abstract] [Full Text] [Related]

  • 39. [PRIMARY DYSMENORRHEA. TRIAL TREATMENT WITH A DERIVATIVE OF RYE ERGOT].
    CHABRIER J, BARRIER J.
    Rev Fr Gynecol Obstet; 1964 Aug 22; 59():345-53. PubMed ID: 14169676
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.